The prevalence and outcome of short-acting β2-agonists overuse in asthma patients in Taiwan
Abstract This study aims to investigate the prevalence of short-acting β2-agonist (SABA) overuse in asthma and the associated risk of acute exacerbation and mortality in Taiwan. We used the Taiwanese pay-for-performance asthma program database, which included patients aged between 12 and 100 years w...
Guardado en:
Autores principales: | Cheng-Yi Wang, Chih-Cheng Lai, Ya-Hui Wang, Hao-Chien Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7d916fe16ae146a6a723749a03fcd30e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Beta-agonist overuse and delay in obtaining medical review in high risk asthma: a secondary analysis of data from a randomised controlled trial
por: Janine Pilcher, et al.
Publicado: (2017) -
The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β2-agonists in the United Kingdom: a cross-sectional analysis
por: Ian D. Pavord, et al.
Publicado: (2017) -
The use of electronic alerts in primary care computer systems to identify the over-prescription of short-acting beta2-agonists in people with asthma: a protocol for a systematic review
por: Shauna McKibben, et al.
Publicado: (2017) -
Perceptions of asthma control in the United Kingdom: a cross-sectional study comparing patient and healthcare professionals’ perceptions of asthma control with validated ACT scores
por: Andrew Menzies-Gow, et al.
Publicado: (2017) -
Can vitamin D3 supplementation reduce the time to severe asthma exacerbations in children with asthma?
por: Idan Bokobza, et al.
Publicado: (2021)